癌症中VHL无活化的ID2依赖机制
Sang Bae Lee1, Veronique Frattini1, Mukesh Bansal2,3
1Institute for Cancer Genetics, Columbia University Medical Center, New York 10032, USA.
Nature
|January 7, 2016
概括
DYRK1激酶通过化ID2来调节癌症干细胞的维持,这会影响HIF2α的稳定性. 这一发现为质母细胞瘤和其他癌症提供了新的治疗点.
科学领域:
- 癌症学
- 分子生物学
- 生物化学
背景情况:
- 癌症干细胞 (CSC) 驱动瘤的进展,并通过特定的分子机制维持.
- HIF2α (低氧诱导因子2α) 对于CSC的维持至关重要,但调节其在CSC中的积累的途径尚未完全理解.
- 已知ID2蛋白支持癌症特征,包括CSC状态.
研究的目的:
- 阐明癌症干细胞中涉及ID2和HIF2α积累的途径.
- 研究DYRK1A和DYRK1B激酶在调节ID2和HIF2α中的作用.
- 探索质母细胞瘤中向这种途径的治疗潜力.
主要方法:
- 通过DYRK1A和DYRK1B激酶对ID2的酸化进行了研究.
- 研究了低氧和正常氧对DYRK1激酶活性和ID2酸化的影响.
- 分析了ID2,VHL泛素联酶复合体和HIF2α泛存在和降解之间的相互作用.
- 评估DYRK1介导的ID2化对患者模型中的HIF2α稳定性和质母细胞瘤干性的影响.
主要成果:
- DYRK1A和DYRK1B激酶在Thr27中化ID2,这种修饰是由低氧降低的.
- 在normoxia中,DYRK1激酶活动受到PHD1的刺激.
- ID2 与VHL复合体结合,抑制HIF2α无处不在和降解;Thr27酸化阻断了这种相互作用,保持HIF2α的稳定性.
- 在质母细胞瘤中,DYRK1活性升高导致ID2酸化,HIF2α不稳定,减少质母细胞瘤干,并改善患者的治疗结果.
结论:
- DYRK1激酶通过ID2酸化调节HIF2α的稳定性,影响癌症干细胞的维持.
- 针对DYRK1-ID2-HIF2α轴是质母细胞瘤和其他由CSC驱动的癌症的潜在治疗策略.
- 了解这种调节途径可以了解瘤的进展, 并为新的癌症疗法提供途径.
更多相关视频
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Loss of Tumor Suppressor Gene Functions
5.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Mechanisms of Retrovirus-induced Cancers
6.8K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K


